REMEDIUM LIFECARE
|
REMEDIUM LIFECARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 |
| CEPS(Rs) | 0.03 | 0.57 | 0.10 | 0.03 | 0.01 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 1.07 | 4.26 | 28.79 | 13.72 | 10.72 |
| Tax Rate(%) | 58.19 | 35.13 | 26.63 | 29.33 | 26.41 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 0.24 | 0.85 | 1.41 | 0.36 | 0.80 |
| EBIT Margin(%) | 5.08 | 1.37 | 1.54 | 0.35 | 0.74 |
| Pre Tax Margin(%) | 1.65 | 1.25 | 1.45 | 0.30 | 0.73 |
| PAT Margin (%) | 0.69 | 0.81 | 1.06 | 0.21 | 0.53 |
| Cash Profit Margin (%) | 0.71 | 0.81 | 1.09 | 0.23 | 0.60 |
| Performance Ratios | |||||
| ROA(%) | 0.09 | 2.11 | 0.79 | 0.82 | 2.25 |
| ROE(%) | 3.55 | 122.76 | 70.92 | 24.51 | 13.33 |
| ROCE(%) | 1.76 | 99.51 | 102.54 | 18.16 | 7.39 |
| Asset Turnover(x) | 0.13 | 2.61 | 0.74 | 3.85 | 4.21 |
| Sales/Fixed Asset(x) | 996.41 | - | 1,909.86 | 1,621.56 | 339.30 |
| Working Capital/Sales(x) | 5.15 | 94.25 | 49.60 | 106.23 | 6.36 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | - | - | - |
| Receivable days | 1,239.80 | 49.35 | 84.61 | 31.70 | 51.05 |
| Inventory Days | 330.23 | 6.35 | 32.64 | 31.45 | 7.72 |
| Payable days | 872.57 | 36.33 | 77.15 | 54.31 | 50.25 |
| Valuation Parameters | |||||
| PER(x) | 33.43 | 5.83 | 1.75 | 46.26 | 32.97 |
| PCE(x) | 46.72 | 33.36 | 47.61 | 43.30 | 29.30 |
| Price/Book(x) | 1.69 | 25.46 | 25.62 | 10.10 | 4.11 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 5.45 | 0.28 | 0.48 | 0.10 | 0.28 |
| EV/Core EBITDA(x) | 106.97 | 20.80 | 30.47 | 26.52 | 35.05 |
| EV/EBIT(x) | 107.34 | 20.82 | 31.06 | 27.64 | 38.20 |
| EV/CE(x) | 1.02 | 11.42 | 23.51 | 9.81 | 1.78 |
| M Cap / Sales | 0.33 | 0.27 | 0.52 | 0.10 | 0.18 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -94.49 | 692.75 | 1.00 | 460.67 | 3,015.14 |
| Core EBITDA Growth(%) | -79.49 | 591.52 | 337.97 | 150.61 | 83.73 |
| EBIT Growth(%) | -79.53 | 604.09 | 347.82 | 162.10 | 74.33 |
| PAT Growth(%) | -95.32 | 503.20 | 403.44 | 124.31 | 73.47 |
| EPS Growth(%) | -98.83 | -78.46 | 403.44 | 124.31 | 73.47 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 26.36 | 1.34 | - | - | 2.72 |
| Current Ratio(x) | 1.03 | 1.02 | 1.01 | 1.02 | 1.59 |
| Quick Ratio(x) | 0.85 | 0.95 | 1.00 | 0.64 | 1.46 |
| Interest Cover(x) | 1.48 | 11.55 | 17.46 | 7.72 | 43.12 |
| Total Debt/Mcap(x) | 15.55 | 0.05 | - | - | 0.66 |
Compare Financial Ratios of peers of REMEDIUM LIFECARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| REMEDIUM LIFECARE | ₹137.6 Cr | 0.7% | 6.1% | -63.3% | Stock Analytics | |
| ADANI ENTERPRISES | ₹286,404.0 Cr | -0.5% | -1% | -9.8% | Stock Analytics | |
| REDINGTON | ₹19,845.3 Cr | -3.1% | -10.4% | 53.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,447.7 Cr | 2.5% | 9.5% | 72.8% | Stock Analytics | |
| MMTC | ₹10,302.0 Cr | 2.5% | 6.2% | -6.8% | Stock Analytics | |
| HONASA CONSUMER | ₹9,255.1 Cr | 5.1% | 1.4% | -31.7% | Stock Analytics | |
REMEDIUM LIFECARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| REMEDIUM LIFECARE | 0.7% |
6.1% |
-63.3% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses
